MK Blend combines ibutamoren (MK-677), a growth-hormone secretagogue, with ostarine (MK-2866), an investigational selective androgen receptor modulator. Research has examined their respective effects on growth-hormone signaling, androgen receptor activity, muscle, and bone physiology. The combination is not an approved human therapeutic treatment. Evidence supporting combined fitness use is lacking, while potential concerns include hormonal disruption, glucose abnormalities, liver effects, unfavorable lipid changes, and cardiovascular or reproductive complications.